Antibody-based technique holds promise for children in "bubbles"

09/2/2009 | BBC

U.K. doctors have developed a technique that could eliminate the need for chemotherapy drugs to administer a bone marrow transplant in children suffering from primary immunodeficiencies, or genetic disorders affecting the immune system, and who must live in "bubbles," or sterile environments. The treatment uses an antibody, which homes in on a molecule linked to blood and bone cells, to wipe out a patient's bone marrow and provide space for donor stem cells.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide